Leidos (NYSE:LDOS) Announces Earnings Results

Leidos (NYSE:LDOS) announced its quarterly earnings results on Tuesday. The aerospace company reported $2.29 EPS for the quarter, beating the consensus estimate of $1.70 by $0.59, RTT News reports. The firm had revenue of $3.98 billion for the quarter, compared to analyst estimates of $3.82 billion. Leidos had a return on equity of 25.66% and a net margin of 2.04%. The business’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.47 earnings per share. Leidos updated its FY 2024 guidance to 8.400-8.800 EPS and its FY24 guidance to $8.40-8.80 EPS.

Leidos Price Performance

Shares of NYSE LDOS opened at $142.21 on Thursday. The company has a debt-to-equity ratio of 1.07, a quick ratio of 1.24 and a current ratio of 1.35. The company has a market cap of $19.22 billion, a PE ratio of 61.30, a P/E/G ratio of 1.75 and a beta of 0.66. The business has a 50-day simple moving average of $128.44 and a two-hundred day simple moving average of $114.73. Leidos has a fifty-two week low of $76.58 and a fifty-two week high of $142.90.

Leidos Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Tuesday, May 14th will be issued a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 1.07%. The ex-dividend date is Friday, June 14th. Leidos’s dividend payout ratio is presently 65.52%.

Wall Street Analysts Forecast Growth

LDOS has been the topic of several research reports. Barclays upgraded Leidos from an “equal weight” rating to an “overweight” rating in a research note on Friday, January 5th. Jefferies Financial Group raised their price target on Leidos from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Wednesday, April 10th. Bank of America raised their price target on Leidos from $125.00 to $145.00 and gave the company a “buy” rating in a research note on Wednesday, March 27th. Truist Financial restated a “buy” rating and set a $165.00 price target (up previously from $150.00) on shares of Leidos in a research note on Wednesday. Finally, Robert W. Baird raised their price objective on Leidos from $145.00 to $180.00 and gave the company an “outperform” rating in a research report on Wednesday. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, Leidos presently has a consensus rating of “Moderate Buy” and a consensus price target of $141.17.

Insiders Place Their Bets

In related news, Director David G. Fubini sold 7,874 shares of Leidos stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the completion of the sale, the director now owns 14,696 shares of the company’s stock, valued at $1,879,471.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director David G. Fubini sold 7,874 shares of Leidos stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the completion of the sale, the director now owns 14,696 shares of the company’s stock, valued at $1,879,471.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gary Stephen May sold 2,745 shares of Leidos stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total value of $341,725.05. Following the transaction, the director now owns 11,352 shares of the company’s stock, valued at $1,413,210.48. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.